{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a bioactivity metric (IC50, Ki, Kd, EC50), a specific numeric value, and a unit for that value."}
{"raw_mentions": "Here are the extracted sentences with concrete data points that meet the specified criteria:\n\n\nAs used herein, the term \"selective \u03b1-2A antagonist\" means a compound having (1) an efficacy of less than 25% relative to brimonidine at \u03b1-2A; (2) a Ki of less than 100 nM at \u03b1-2A; and further having (3) at least a 10-fold greater Ki at \u03b1-2B than at \u03b1-2A or an efficacy of greater than 25% relative to brimonidine at \u03b1-2B.\nA selective \u03b1-2A antagonist can be a peripherally limited compound, and a compound having \u03b1-2C antagonist activity, characterized by a Ki at \u03b1-2C of less than 100 nM and an efficacy at \u03b1-2C of less than 25% relative to brimonidine, is encompassed by the term \"selective \u03b1-2A antagonist\".\nCompound 13 exhibits \u03b1-2B agonist activity characterized by about 40% efficacy at \u03b1-2B relative to brimonidine, and further has (1) an efficacy of 5% relative to brimonidine at \u03b1-2A and (2) a Ki of about 0.08 nM at \u03b1-2A.\nIn particular embodiments, a method of the invention is practiced with a selective \u03b1-2A antagonist having a Ki of less than 80 nM, 60 nM, 40 nM, 20 nM, 10 nM, 1 nM or 0.1 nM.\nIn one embodiment, the invention relies on a selective \u03b1-2A antagonist with minimal \u03b1-2B antagonist activity, means a selective \u03b1-2A antagonist, as defined hereinabove, further having a Ki at \u03b1-2B greater than 100 nM, such as a Ki at \u03b1-2B of greater than 200 nM, 300 nM, 400 nM, 500 nM, 1000 nM, 2000 nM, 3000 nM, 4000 nM or 5000 nM.\nAs used herein, the term \"specific \u03b1-2A antagonist\" means a compound having (1) an efficacy of less than 25% relative to brimonidine at \u03b1-2A; (2) a Ki of less than 100 nM at \u03b1-2A; and further having (3) at each of the \u03b1-adrenergic receptors other than \u03b1-2A either at least a 10-fold greater Ki than at \u03b1-2A or an efficacy of greater than 25% relative to brimonidine or phenylephrine."}
{"final_json": [{"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<100", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "efficacy", "value": "<25", "unit": "%"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">10-fold greater than at \u03b1-2A", "unit": null}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "efficacy", "value": ">25", "unit": "%"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2C", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<100", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2C", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "efficacy", "value": "<25", "unit": "%"}, {"molecule_name": "Compound 13", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "efficacy", "value": "40", "unit": "%"}, {"molecule_name": "Compound 13", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "efficacy", "value": "5", "unit": "%"}, {"molecule_name": "Compound 13", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "0.08", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<80", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<60", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<40", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<20", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<10", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<1", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<0.1", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">100", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">200", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">300", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">400", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">500", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">1000", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">2000", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">3000", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">4000", "unit": "nM"}, {"molecule_name": "selective \u03b1-2A antagonist", "protein_target_name": "\u03b1-2B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": ">5000", "unit": "nM"}, {"molecule_name": "specific \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "efficacy", "value": "<25", "unit": "%"}, {"molecule_name": "specific \u03b1-2A antagonist", "protein_target_name": "\u03b1-2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "<100", "unit": "nM"}]}
{"raw_mentions": "None"}
